August 19, 2016
Genetic medicines company WAVE Life Sciences Ltd. (Cambridge, MA) announced that it has appointed Keith Regnante as the company’s Chief Financial Officer.
Mr. Regnante was formerly VP of Finance at Shire where he oversaw finance for R&D. Earlier in his career he was a consultant with Boston Consulting Group.
Can Data and AI Deliver Whole-Person Health?
July 9th 2024Executives in the life sciences and medical device industries see promise in artificial intelligence (AI) and medical technologies, but must also navigate the changing healthcare ecosystem, varied stakeholder needs, and the impact of AI on market access and commercialization strategies.